| abstract |
The disclosure relates to a pharmaceutical composition which includes one or more salts of anticholinergenic agent of formula 1 wherein X - denotes bromide optionally in the form of a racemate, a enantiomer, and a hydrate thereof, combined with the steroid budesonide, optionally in the form of an enantiomer, mixtures of enantiomers, a racemate, a solvate or a hydrate, and optionally together with a pharmaceutically acceptable excipient. Also disclosed is the use of the pharmaceutical composition in preparing a medicament for the treatment of an inflammatory or obstructive respiratory condition. |